UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$602M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$296M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$256M |
| 4 |
Enterprise Products Partners
EPD
|
+$252M |
| 5 |
Charter Communications
CHTR
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.22B |
| 2 |
CVS Health
CVS
|
+$465M |
| 3 |
Mondelez International
MDLZ
|
+$382M |
| 4 |
SHPG
Shire pic
SHPG
|
+$221M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$139M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 7.78% |
| 2 | Technology | 7.19% |
| 3 | Healthcare | 5.6% |
| 4 | Industrials | 5.06% |
| 5 | Consumer Discretionary | 4.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Boise Cascade
BCC
$2.69B
| $6.72M | ﹤0.01% |
168,534
+133,396
| +380% | +$4.94M |
|
2052
Qorvo
QRVO
$7.99B
| $6.71M | ﹤0.01% |
100,838
+52,931
| +110% | +$3.86M |
|
|
XLRN
2053
DELISTED
Acceleron Pharma
XLRN
| $6.71M | ﹤0.01% |
158,201
-2,629
| -2% | -$98.6K |
|
2054
Agnico Eagle Mines
AEM
$73.6B
| $6.7M | ﹤0.01% |
144,972
-23,365
| -14% | -$1.04M |
|
|
FCRD
2055
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
| $6.69M | ﹤0.01% |
739,193
-60,781
| -8% | -$563K |
|
2056
Booz Allen Hamilton
BAH
$8.39B
| $6.68M | ﹤0.01% |
175,182
-39,074
| -18% | -$1.48M |
|
|
RGC
2057
DELISTED
Regal Entertainment Group
RGC
| $6.67M | ﹤0.01% |
289,910
+119,050
| +70% | +$2.19M |
|
|
NGD
2058
DELISTED
New Gold Inc
NGD
| $6.67M | ﹤0.01% |
2,025,896
-261,431
| -11% | -$878K |
|
2059
PUT
Tapestry
TPR
$30.8B
| $6.65M | ﹤0.01% |
150,300
| – | – |
|
2060
WisdomTree Emerging Markets Local Debt Fund
ELD
$142M
| $6.64M | ﹤0.01% |
172,581
+13,342
| +8% | +$508K |
|
|
SPLK
2061
PUT
DELISTED
Splunk Inc
SPLK
| $6.63M | ﹤0.01% |
80,000
| – | – |
|
2062
SPX Corp
SPXC
$11B
| $6.62M | ﹤0.01% |
210,968
+40,719
| +24% | +$1.23M |
|
|
CMD
2063
DELISTED
Cantel Medical Corporation
CMD
| $6.61M | ﹤0.01% |
64,254
+4,834
| +8% | +$482K |
|
2064
CALL
Intuitive Surgical
ISRG
$127B
| $6.61M | ﹤0.01% |
54,300
+30,000
| +123% | +$3.75M |
|
|
HPP
2065
Hudson Pacific Properties
HPP
$747M
| $6.6M | ﹤0.01% |
27,524
+8,177
| +42% | +$1.97M |
|
2066
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$1.38B
| $6.59M | ﹤0.01% |
180,253
+63,024
| +54% | +$2.23M |
|
2067
BGC Group
BGC
$5.52B
| $6.59M | ﹤0.01% |
678,450
+91,954
| +16% | +$928K |
|
|
PCN
2068
PIMCO Corporate & Income Strategy Fund
PCN
$870M
| $6.59M | ﹤0.01% |
383,171
+34,106
| +10% | +$579K |
|
|
SGEN
2069
DELISTED
Seagen Inc. Common Stock
SGEN
| $6.59M | ﹤0.01% |
123,099
-74,119
| -38% | -$4.33M |
|
2070
Nuveen Municipal High Income Opportunity Fund
NMZ
$2.19B
| $6.58M | ﹤0.01% |
483,229
+21,008
| +5% | +$287K |
|
|
ALXN
2071
PUT
DELISTED
Alexion Pharmaceuticals
ALXN
| $6.58M | ﹤0.01% |
55,000
+25,000
| +83% | +$3.04M |
|
2072
PUT
Abercrombie & Fitch
ANF
$4.42B
| $6.55M | ﹤0.01% |
376,000
-474,000
| -56% | -$7.2M |
|
2073
Acadia Pharmaceuticals
ACAD
$4.43B
| $6.55M | ﹤0.01% |
217,622
-35,213
| -14% | -$1.13M |
|
2074
PBF Energy
PBF
$8.57B
| $6.55M | ﹤0.01% |
184,674
+61,767
| +50% | +$1.91M |
|
|
MRCC
2075
DELISTED
Monroe Capital Corp
MRCC
| $6.53M | ﹤0.01% |
474,927
-21,616
| -4% | -$310K |
|
Similar funds
UBS Group's Q4 2017 Portfolio in Review
As of Q4 2017, UBS Group held 8,546 positions worth $243B, up 13% from $216B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS Group deployed $15.3B of net new capital in Q4 2017, opening 751 new positions and adding to 3,655 existing holdings. Its largest new stake was Columbia Diversified Fixed Income Allocation ETF: 857,912 shares worth $17.1M.
By sector, the portfolio is most concentrated in Financials at 7.8% of assets, up from 7.2% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $4.22B trimmed.
- UBS Group's largest Q4 2017 buy was Columbia Diversified Fixed Income Allocation ETF: 857,912 shares worth $17.1M.
- UBS Group added most to Apple in Q4 2017, an estimated $602M increase.
- UBS Group's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.22B.
- UBS Group fully exited Level 3 Communications Inc in Q4 2017, selling an estimated $139M.
- UBS Group's ten largest holdings make up 15% of its $243B portfolio in Q4 2017.
- UBS Group opened 751 new positions and closed 634 in Q4 2017.
- UBS Group's portfolio value rose 13% quarter-over-quarter to $243B.
Based on UBS Group's 13F filing for Q4 2017, filed 14 Feb 2018.